CUTISS AG

CUTISS AG, a Swiss biotechnology company, is developing skin tissue therapeutics and dedicated to bioengineering by transforming skin surgery with denovoSkin™, its first-in-class personalized tissue therapy that enables automated, on-demand production of living skin at scale. The company is headquartered in Switzerland.

Here are key aspects of the company:

• Products & Services: CUTISS offers denovoSkin™, the only living, true human skin available on demand for patients requiring skin surgery ranging from massive burns to reconstructive and aesthetic applications.
• Innovation: The company has developed a first-in-class automation platform featuring a patented, fully-closed, end-to-end system that enables decentralized production of personalized tissue therapy with high scalability.
• Industries: Beyond healthcare, the organization is expanding into regenerative medicine to develop next-priority tissues such as gums, cornea, and muscle, while also contributing to Space Health research for discoveries in healing and ageing.

CUTISS AG stands out as a pioneering force in bioengineering by combining advanced automation with personalized tissue therapy to address critical needs in skin surgery and future medical frontiers.